564 reports of this reaction
3.3% of all PYRAZINAMIDE reports
#4 most reported adverse reaction
DRUG INTERACTION is the #4 most commonly reported adverse reaction for PYRAZINAMIDE, manufactured by ANI Pharmaceuticals, Inc.. There are 564 FDA adverse event reports linking PYRAZINAMIDE to DRUG INTERACTION. This represents approximately 3.3% of all 17,268 adverse event reports for this drug.
Patients taking PYRAZINAMIDE who experience drug interaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INTERACTION is moderately reported among PYRAZINAMIDE users, representing a notable but not dominant share of adverse events.
In addition to drug interaction, the following adverse reactions have been reported for PYRAZINAMIDE:
The following drugs have also been linked to drug interaction in FDA adverse event reports:
DRUG INTERACTION has been reported as an adverse event in 564 FDA reports for PYRAZINAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INTERACTION accounts for approximately 3.3% of all adverse event reports for PYRAZINAMIDE, making it a notable side effect.
If you experience drug interaction while taking PYRAZINAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.